{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:20:34Z","timestamp":1792844434908,"version":"4.5.0"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth)"},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"crossref","award":["CNPq\/443826\/2014-5"],"award-info":[{"award-number":["CNPq\/443826\/2014-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005667","name":"Foundation for Research and Innovation of the State of Santa Catarina","doi-asserted-by":"crossref","award":["FAPESC1079\/2016"],"award-info":[{"award-number":["FAPESC1079\/2016"]}],"id":[{"id":"10.13039\/501100005667","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013379","name":"Instituto C\u00e9rebro e Mente","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013379","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013360","name":"UNESC","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013360","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jpsychires.2017.03.018","type":"journal-article","created":{"date-parts":[[2017,3,29]],"date-time":"2017-03-29T15:17:15Z","timestamp":1490800635000},"page":"160-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":189,"special_numbering":"C","title":["A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients"],"prefix":"10.1016","volume":"92","author":[{"given":"Pavani","family":"Sayana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela Delevati","family":"Colpo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutiana R.","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijayasree Vayalanellore","family":"Giridharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Lucio","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3114-6611","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Quevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Barichello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2017.03.018_bib83","first-page":"3318","article-title":"Myeloperoxidase enzyme levels and oxidative stress in bipolar disorders","volume":"9","author":"Aksoy","year":"2010","journal-title":"Afr. J. Biotechnol."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000258696","article-title":"The MCP-1 gene (SCYA2) and mood disorders: preliminary results of a case-control association study","volume":"17","author":"Altamura","year":"2010","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.jpsychires.2017.03.018_bib2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/bdi.12259","article-title":"Comparison of pro-inflammatory cytokines among patients with bipolar disorder and unipolar depression and normal controls","volume":"17","author":"Bai","year":"2015","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jad.2014.05.009","article-title":"Comparison of inflammatory cytokine levels among type I\/type II and manic\/hypomanic\/euthymic\/depressive states of bipolar disorder","volume":"166","author":"Bai","year":"2014","journal-title":"J.\u00a0Affect Disord."},{"issue":"2","key":"10.1016\/j.jpsychires.2017.03.018_bib84","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00406-010-0116-z","article-title":"Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder","volume":"261","author":"Barbosa","year":"2011","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jad.2013.12.042","article-title":"A\u00a0preliminary report of increased plasma levels of IL-33 in bipolar disorder: further evidence of pro-inflammatory status","volume":"157","author":"Barbosa","year":"2014","journal-title":"J.\u00a0Affect Disord."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib85","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.jpsychires.2013.08.019","article-title":"Altered intracellular signaling cascades in peripheral blood mononuclear cells from BD patients","volume":"47","author":"Barbosa","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib86","article-title":"Monocyte and lymphocyte activation in bipolar disorder: a new piece in the puzzle of immune dysfunction in mood disorders","volume":"18","author":"Barbosa","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00406-012-0327-6","article-title":"Chemokines in bipolar disorder: trait or state?","volume":"263","author":"Barbosa","year":"2013","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jpsychires.2011.11.010","article-title":"Increased levels of adipokines in bipolar disorder","volume":"46","author":"Barbosa","year":"2012","journal-title":"J.\u00a0Psychiatr. Res."},{"issue":"10","key":"10.1016\/j.jpsychires.2017.03.018_bib88","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.biopsych.2013.03.010","article-title":"Not all inflammatory biomarkers are elevated in bipolar disorder: evidence for procalcitonin","volume":"74","author":"Barbosa","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.03.018_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jad.2011.12.034","article-title":"Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkers","volume":"137","author":"Barbosa","year":"2012","journal-title":"J.\u00a0Affect Disord."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib8","first-page":"87","article-title":"The association between immune activation and manic symptoms in patients with a depressive disorder","volume":"22","author":"Becking","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.03.018_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.psc.2015.09.002","article-title":"Suicide behaviors in bipolar disorder: a review and update for the clinician","volume":"39","author":"Beyer","year":"2016","journal-title":"Psychiatr. Clin. North Am."},{"issue":"2","key":"10.1016\/j.jpsychires.2017.03.018_bib89","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jad.2004.01.007","article-title":"Cytokine production in bipolar affective disorder patients under lithium treatment","volume":"82","author":"Boufidou","year":"2004","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib10","first-page":"46","article-title":"Increased M1\/decreased M2 signature and signs of Th1\/Th2 shift in chronic patients with bipolar disorder, but not in those with schizophrenia","volume":"1","author":"Brambilla","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.03.018_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-3223(02)01452-X","article-title":"High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder","volume":"53","author":"Breunis","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.03.018_bib12","doi-asserted-by":"crossref","first-page":"107982","DOI":"10.1016\/j.bbi.2009.04.008","article-title":"Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder","volume":"23","author":"Brietzke","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jad.2008.12.001","article-title":"Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder","volume":"116","author":"Brietzke","year":"2009","journal-title":"J.\u00a0Affect Disord."},{"issue":"2","key":"10.1016\/j.jpsychires.2017.03.018_bib90","first-page":"180","article-title":"Increased neutrophil\/lymphoctye ratio in patients with bipolar disorder: a preliminary study","volume":"27","author":"Cakir","year":"2015","journal-title":"Psychiatr. Danub"},{"issue":"1","key":"10.1016\/j.jpsychires.2017.03.018_bib91","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1034\/j.1600-0447.2002.0_435.x","article-title":"Leukocytosis and hypoalbuminemia in mixed bipolar states: evidence for immune activation","volume":"105","author":"Cassidy","year":"2002","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib14","first-page":"695","article-title":"Pro- versus anti-inflammatory cytokines: myth or reality","volume":"47","author":"Cavaillon","year":"2001","journal-title":"Cell Mol. Biol."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-244X-12-158","article-title":"Plasma concentrations of soluble cytokine receptors in euthymic bipolar patients with and without subsyndromal symptoms","volume":"12","author":"Cetin","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.03.018_bib16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000353613","article-title":"The link between highsensitivity C-reactive protein and orbitofrontal cortex in euthymic bipolar disorder","volume":"68","author":"Chung","year":"2013","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jpsychires.2017.03.018_bib17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1017\/S1092852900020393","article-title":"Cytokine polymorphisms in the pathophysiology of mood disorders","volume":"14","author":"Clerici","year":"2009","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00406-007-0797-0","article-title":"Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder","volume":"258","author":"Cunha","year":"2008","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000135642","article-title":"Association of tumor necrosis factor -308G\/A promoter polymorphism with schizophrenia and bipolar affective disorder in a Polish population","volume":"57","author":"Czerski","year":"2008","journal-title":"Neuropsychobiology"},{"issue":"2-3","key":"10.1016\/j.jpsychires.2017.03.018_bib92","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.schres.2014.10.055","article-title":"Innate immune response is differentially dysregulated between bipolar disease and schizophrenia","volume":"161","author":"de Baumont","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/039463200802100208","article-title":"Evaluation of C-reactive protein and total serum cholesterol in adult patients with bipolar disorder","volume":"21","author":"De Berardis","year":"2008","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"7","key":"10.1016\/j.jpsychires.2017.03.018_bib93","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/mp.2012.95","article-title":"Different changes in cortical tumor necrosis factor-alpha-related pathways in schizophrenia and mood disorders","volume":"18","author":"Dean","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.03.018_bib21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/acps.12451","article-title":"Immune alterations in acute bipolar depression","volume":"132","author":"Dickerson","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib22","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.pnpbp.2007.02.018","article-title":"Elevated serum levels of Creactive protein are associated with mania symptoms in outpatients with bipolar disorder","volume":"31","author":"Dickerson","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.03.018_bib23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/bdi.12281","article-title":"Pentraxin 3 is reduced in bipolar disorder","volume":"17","author":"Dickerson","year":"2015","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib24","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jad.2013.04.039","article-title":"Elevated Creactive protein and cognitive deficits in individuals with bipolar disorder","volume":"150","author":"Dickerson","year":"2013","journal-title":"J.\u00a0Affect Disord."},{"issue":"5","key":"10.1016\/j.jpsychires.2017.03.018_bib94","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.psyneuen.2012.08.005","article-title":"Reduced regulatory T cells are associated with higher levels of Th1\/TH17 cytokines and activated MAPK in type 1 bipolar disorder","volume":"38","author":"do Prado","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jpsychires.2017.03.018_bib25","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1378\/chest.118.2.503","article-title":"cytokines","volume":"118","author":"Dinarello","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.jpsychires.2017.03.018_bib26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jad.2015.03.032","article-title":"Enrichment pathway analysis. The inflammatory genetic background in bipolar disorder","volume":"179","author":"Drago","year":"2015","journal-title":"J.\u00a0Affect Disord."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib27","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1017\/S1461145710000799","article-title":"Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients","volume":"13","author":"Drexhage","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib95","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.bbi.2011.03.013","article-title":"The activation of monocyte and T cell networks in patients with bipolar disorder","volume":"25","author":"Drexhage","year":"2011","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.jpsychires.2017.03.018_bib96","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/2194-7511-2-4","article-title":"Immunological and neurotrophic markers of risk status and illness development in high-risk youth: understanding the neurobiological underpinnings of bipolar disorder","volume":"2","author":"Duffy","year":"2014","journal-title":"Int. J. Bipolar Disord."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib97","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1038\/tp.2014.8","article-title":"Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder","volume":"4","author":"Fillman","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.03.018_bib28","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1089\/cap.2011.0009","article-title":"Preliminary findings regarding pro-inflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders","volume":"21","author":"Goldstein","year":"2011","journal-title":"J.\u00a0Child. Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib29","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/acps.12268","article-title":"Staging bipolar disorder: clinical, biochemical, and functional correlates","volume":"129","author":"Grande","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib30","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jad.2010.04.027","article-title":"Cytokine levels in euthymic bipolar patients","volume":"126","author":"Guloksuz","year":"2010","journal-title":"J.\u00a0Affect Disord."},{"issue":"2","key":"10.1016\/j.jpsychires.2017.03.018_bib98","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/bdi.12142","article-title":"Relationship between clinical features and inflammation-related monocyte gene expression in bipolar disorder - towards a better understanding of psychoimmunological interactions","volume":"16","author":"Haarman","year":"2014","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jad.2013.12.008","article-title":"Multiplex immunoassay analysis of plasma shows prominent upregulation of growth factor activity pathways linked to GSK3beta signaling in bipolar patients","volume":"156","author":"Haenisch","year":"2014","journal-title":"J.\u00a0Affect Disord."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/pmic.201000291","article-title":"Peripheral profiling analysis for bipolar disorder reveals markers associated with reduced cell survival","volume":"11","author":"Herberth","year":"2011","journal-title":"Proteomics"},{"key":"10.1016\/j.jpsychires.2017.03.018_bib33","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jpsychires.2011.08.003","article-title":"Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia","volume":"45","author":"Hope","year":"2011","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib34","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.schres.2015.04.004","article-title":"Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls","volume":"165","author":"Hope","year":"2015","journal-title":"Schizophr. Res."},{"issue":"7","key":"10.1016\/j.jpsychires.2017.03.018_bib99","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1399-5618.2009.00757.x","article-title":"Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor","volume":"11","author":"Hope","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.schres.2012.12.023","article-title":"Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder","volume":"145","author":"Hope","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/acps.12467","article-title":"Association between cytokine levels, verbal memory and hippocampus volume in psychotic disorders and healthy controls","volume":"133","author":"Hoseth","year":"2016","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/bdi.12164","article-title":"Association of thalamic serotonin transporter and interleukin-10 in bipolar I disorder: a SPECT study","volume":"16","author":"Hsu","year":"2014","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib38","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.pnpbp.2006.09.010","article-title":"High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar mania","volume":"31","author":"Huang","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.03.018_bib39","doi-asserted-by":"crossref","first-page":"198204","DOI":"10.1016\/j.bbi.2014.10.001","article-title":"Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment","volume":"43","author":"Isgren","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib40","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1503\/jpn.140183","article-title":"Monocyte and microglial activation in patients with mood-stabilized bipolar disorder","volume":"40","author":"Jakobsson","year":"2015","journal-title":"J.\u00a0Psychiatry Neurosci."},{"issue":"2","key":"10.1016\/j.jpsychires.2017.03.018_bib100","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jpsychires.2010.05.015","article-title":"Peripheral biomarkers and illness activity in bipolar disorder","volume":"45","author":"Kapczinski","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib41","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1017\/S1461145708009310","article-title":"Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder","volume":"12","author":"Kauer-Sant'Anna","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2147\/TACG.S39297","article-title":"Genetics of bipolar disorder","volume":"7","author":"Kerner","year":"2014","journal-title":"Appl. Clin. Genet."},{"issue":"3","key":"10.1016\/j.jpsychires.2017.03.018_bib101","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/mp.2015.79","article-title":"Differential activation of immune\/inflammatory response-related co-expression modules in the hippocampus across the major psychiatric disorders","volume":"21","author":"Kim","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.03.018_bib43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2007.02.018","article-title":"Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder","volume":"104","author":"Kim","year":"2007","journal-title":"J.\u00a0Affect Disord."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib44","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.psychres.2004.08.005","article-title":"T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients","volume":"129","author":"Kim","year":"2004","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib45","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/sj.mp.4001084","article-title":"The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs","volume":"7","author":"Kim","year":"2002","journal-title":"Mol. Psychiatry"},{"issue":"7","key":"10.1016\/j.jpsychires.2017.03.018_bib102","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1399-5618.2007.00444.x","article-title":"An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: restoration by lithium treatment","volume":"9","author":"Knijff","year":"2007","journal-title":"Bipolar Disord."},{"issue":"3","key":"10.1016\/j.jpsychires.2017.03.018_bib46","first-page":"268","article-title":"Serum levels of IL-6, IL-10 and TNF-alpha in patients with bipolar disorder and schizophrenia: differences in pro- and antiinflammatory balance","volume":"33","author":"Kunz","year":"2011","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib47","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jad.2014.12.033","article-title":"IL-23 and TGF-beta1 levels as potential predictive biomarkers in treatment of bipolar I disorder with acute manic episode","volume":"174","author":"Li","year":"2015","journal-title":"J.\u00a0Affect Disord."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib48","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jad.2011.08.003","article-title":"Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression","volume":"139","author":"Liu","year":"2012","journal-title":"J.\u00a0Affect Disord."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib103","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jneuroim.2004.01.006","article-title":"Immunologic variables in acute mania of bipolar disorder","volume":"150","author":"Liu","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib49","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/gps.4048","article-title":"The relationship between interleukin-1 receptor antagonist and cognitive function in older adults with bipolar disorder","volume":"29","author":"Lotrich","year":"2014","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.03.018_bib50","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0022-3956(94)00049-W","article-title":"Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers","volume":"29","author":"Maes","year":"1995","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-1781(96)02915-0","article-title":"Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs","volume":"66","author":"Maes","year":"1997","journal-title":"Psychiatry Res."},{"issue":"10","key":"10.1016\/j.jpsychires.2017.03.018_bib52","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jpsychires.2011.05.008","article-title":"Systemic toxicity in early-stage mood disorders","volume":"45","author":"Magalhaes","year":"2011","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib53","first-page":"37","article-title":"Enhanced peripheral tolllike receptor responses in psychosis: further evidence of a pro-inflammatory phenotype","volume":"30","author":"McKernan","year":"2011","journal-title":"Transl. Psychiatry"},{"issue":"8","key":"10.1016\/j.jpsychires.2017.03.018_bib54","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/sj.mp.4001309","article-title":"Analysis of a polymorphism in the promoter region of the tumor necrosis factor alpha gene in schizophrenia and bipolar disorder: further support for an association with schizophrenia","volume":"8","author":"Meira-Lima","year":"2003","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.03.018_bib55","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00041444-200010040-00008","article-title":"Tumour necrosis factor alpha and bipolar affective puerperal psychosis","volume":"10","author":"Middle","year":"2000","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib56","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.03.018_bib57","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"issue":"7","key":"10.1016\/j.jpsychires.2017.03.018_bib104","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/bdi.12214","article-title":"Immune dysfunction in bipolar disorder and suicide risk: is there an association between peripheral corticotropin-releasing hormone and interleukin-1beta?","volume":"16","author":"Monfrim","year":"2014","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib58","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.jpsychires.2013.08.020","article-title":"Interleukin-1beta is associated with depressive episode in major depression but not in bipolar disorder","volume":"47","author":"Mota","year":"2013","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib59","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbi.2014.09.021","article-title":"Elevated levels of IL-6 and IL-18 in manic and hypomanic states in rapid cycling bipolar disorder patients","volume":"43","author":"Munkholm","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"Suppl.\u00a04","key":"10.1016\/j.jpsychires.2017.03.018_bib60","first-page":"8","article-title":"Antipsychotic medications: metabolic and cardiovascular risk","volume":"68","author":"Newcomer","year":"2007","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.03.018_bib61","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jad.2005.11.015","article-title":"Cytokine profiles in bipolar affective disorder: focus on acutely ill patients","volume":"90","author":"O'Brien","year":"2006","journal-title":"J.\u00a0Affect Disord."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib62","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1399-5618.2007.00493.x","article-title":"Immune variations in bipolar disorder: phasic differences","volume":"9","author":"Ortiz-Dominguez","year":"2007","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib105","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/archpsyc.65.4.395","article-title":"A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes","volume":"65","author":"Padmos","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.03.018_bib63","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archgenpsychiatry.2009.116","article-title":"Genetic and environmental influences on pro-inflammatory monocytes in bipolar disorder: a twin study","volume":"66","author":"Padmos","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.03.018_bib64","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.psychres.2003.06.002","article-title":"Tumor necrosis factor alpha gene-G308A polymorphism associated with bipolar I disorder in the Korean population","volume":"125","author":"Pae","year":"2004","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib65","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jad.2014.12.010","article-title":"Increased serum levels of eotaxin\/CCL11 in late-stage patients with bipolar disorder: an accelerated aging biomarker?","volume":"182","author":"Panizzutti","year":"2015","journal-title":"J.\u00a0Affect Disord."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib66","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1601-183X.2008.00421.x","article-title":"Gray matter deficits in bipolar disorder are associated with genetic variability at interleukin-1 beta gene (2q13)","volume":"7","author":"Papiol","year":"2008","journal-title":"Genes Brain Behav."},{"issue":"3","key":"10.1016\/j.jpsychires.2017.03.018_bib106","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/jmg.2003.012914","article-title":"Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder","volume":"41","author":"Papiol","year":"2004","journal-title":"J. Med. Genet."},{"issue":"3","key":"10.1016\/j.jpsychires.2017.03.018_bib107","doi-asserted-by":"crossref","first-page":"e91076","DOI":"10.1371\/journal.pone.0091076","article-title":"Putative transcriptomic biomarkers in the inflammatory cytokine pathway differentiate major depressive disorder patients from control subjects and bipolar disorder patients","volume":"9","author":"Powell","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2017.03.018_bib67","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/FTD.0b013e31827e18d2","article-title":"A\u00a0pilot study investigating tumor necrosis factor-alpha as a potential intervening variable of atypical antipsychotic-associated metabolic syndrome in bipolar disorder","volume":"35","author":"Prossin","year":"2013","journal-title":"Ther. Drug Monit."},{"issue":"4","key":"10.1016\/j.jpsychires.2017.03.018_bib108","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/mp.2009.47","article-title":"Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients","volume":"15","author":"Rao","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.03.018_bib68","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0022-3956(99)00007-2","article-title":"Immune parameters in rapid cycling bipolar patients before and after lithium treatment","volume":"33","author":"Rapaport","year":"1999","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib69","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000339949","article-title":"Selected cytokine profiles during remission in bipolar patients","volume":"66","author":"Remlinger-Molenda","year":"2012","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jpsychires.2017.03.018_bib70","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.euroneuro.2015.04.023","article-title":"CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment","volume":"25","author":"Rolstad","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib109","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbi.2012.10.007","article-title":"Inflammation and neurological disease-related genes are differentially expressed in depressed patients with mood disorders and correlate with morphometric and functional imaging abnormalities","volume":"31","author":"Savitz","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib71","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pnpbp.2014.06.005","article-title":"Common biological mechanisms between bipolar disorder and type 2 diabetes: focus on inflammation","volume":"54","author":"Sharma","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2017.03.018_bib72","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/pcn.12476","article-title":"Biological hypotheses and biomarkers of bipolar disorder","volume":"71","author":"Sigitova","year":"2017","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib73","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1503\/jpn.100080","article-title":"Elevation of cerebrospinal fluid interleukin-1ss in bipolar disorder","volume":"36","author":"Soderlund","year":"2011","journal-title":"J.\u00a0Psychiatry Neurosci."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib74","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0165-0327(01)00369-X","article-title":"Reduced production of interferon-gamma but not interleukin-10 in bipolar mania and subsequent remission","volume":"71","author":"Su","year":"2002","journal-title":"J.\u00a0Affect Disord."},{"issue":"8","key":"10.1016\/j.jpsychires.2017.03.018_bib110","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0006-3223(98)00159-0","article-title":"Activation of indices of cell-mediated immunity in bipolar mania","volume":"45","author":"Tsai","year":"1999","journal-title":"Biol. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.jpsychires.2017.03.018_bib75","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jad.2011.08.022","article-title":"Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder","volume":"136","author":"Tsai","year":"2012","journal-title":"J.\u00a0Affect Disord."},{"issue":"8","key":"10.1016\/j.jpsychires.2017.03.018_bib76","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/bdi.12240","article-title":"Persistent inflammation and its relationship to leptin and insulin in phases of bipolar disorder from acute depression to full remission","volume":"16","author":"Tsai","year":"2014","journal-title":"Bipolar Disord."},{"issue":"3","key":"10.1016\/j.jpsychires.2017.03.018_bib111","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0022-3956(02)00103-6","article-title":"Plasma levels of soluble transferring receptors and Clara cell protein (CC16) during bipolar mania and subsequent remission","volume":"37","author":"Tsai","year":"2003","journal-title":"J. Psychiatr. Res."},{"issue":"2-3","key":"10.1016\/j.jpsychires.2017.03.018_bib112","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0165-0327(00)00252-4","article-title":"Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania","volume":"64","author":"Tsai","year":"2001","journal-title":"J. Affect Disord."},{"issue":"3","key":"10.1016\/j.jpsychires.2017.03.018_bib113","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.psychres.2015.05.078","article-title":"Assessment of cytokine levels and hs-CRP in bipolar I disorder before and after treatment","volume":"228","author":"Uyanik","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib77","first-page":"275","article-title":"C-reactive protein and metabolic syndrome in patients with bipolar disorder compared to patients with schizophrenia","volume":"22","author":"Vuksan-Cusa","year":"2010","journal-title":"Psychiatr. Danub"},{"key":"10.1016\/j.jpsychires.2017.03.018_bib78","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3109\/08039488.2012.745601","article-title":"Association between C-reactive protein and homocysteine with the subcomponents of metabolic syndrome in stable patients with bipolar disorder and schizophrenia","volume":"67","author":"Vuksan-Cusa","year":"2013","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2017.03.018_bib79","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/hup.390","article-title":"Serological observations in patients suffering from acute manic episodes","volume":"17","author":"Wadee","year":"2002","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2017.03.018_bib80","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neulet.2014.07.040","article-title":"Pro-inflammatory cytokines and soluble receptors in response to acute psychosocial stress: differential reactivity in bipolar disorder","volume":"580","author":"Wieck","year":"2014","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.jpsychires.2017.03.018_bib81","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3109\/08039488.2014.984755","article-title":"Levels of C-reactive protein (CRP) in patients with schizophrenia, unipolar depression and bipolar disorder","volume":"69","author":"Wysokinski","year":"2015","journal-title":"Nord. J. Psychiatry"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395616306331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395616306331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T11:39:56Z","timestamp":1655552396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395616306331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":111,"alternative-id":["S0022395616306331"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2017.03.018","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2017.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}